Connection

Katie Ewer to Malaria, Falciparum

This is a "connection" page, showing publications Katie Ewer has written about Malaria, Falciparum.
Connection Strength

1.160
  1. Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP. Sci Rep. 2018 02 21; 8(1):3390.
    View in: PubMed
    Score: 0.507
  2. Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants. Mol Ther. 2017 02 01; 25(2):547-559.
    View in: PubMed
    Score: 0.471
  3. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine. Infect Immun. 2017 03; 85(3).
    View in: PubMed
    Score: 0.118
  4. Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens. J Immunol. 2018 08 15; 201(4):1315-1326.
    View in: PubMed
    Score: 0.033
  5. Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™. Vaccine. 2017 10 27; 35(45):6208-6217.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.